{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:24:09Z","timestamp":1787844249882,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06135-w","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:15:31Z","timestamp":1787843731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VSIG4 Inhibits Microglia-Mediated Neuroinflammation and Neuronal Injury by Modulating the JAK2-STAT3\/NF-\u03baB Signaling Pathway in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Jingcong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanlong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"6135_CR1","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ (Clinical research ed) 388:e080952","journal-title":"BMJ (Clin Res ed)"},{"issue":"6","key":"6135_CR2","first-page":"1","volume":"82","author":"RP Munhoz","year":"2024","unstructured":"Munhoz RP, Tumas V, Pedroso JL, Silveira-Moriyama L (2024) The clinical diagnosis of Parkinson\u2019s disease. Arq Neuropsiquiatr 82(6):1\u201310","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"6135_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer P, Okkels N, Weintraub D (2024) Parkinson\u2019s disease and dementia with Lewy bodies: one and the same. J Parkinsons Dis 14(3):383\u2013397","journal-title":"J Parkinsons Dis"},{"key":"6135_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101840","volume":"85","author":"MH Ahmad","year":"2023","unstructured":"Ahmad MH, Rizvi MA, Ali M, Mondal AC (2023) Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev 85:101840","journal-title":"Ageing Res Rev"},{"key":"6135_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101834","volume":"84","author":"ABR Leite Silva","year":"2023","unstructured":"Leite Silva ABR, Gon\u00e7alves de Oliveira RW, Di\u00f3genes GP, de Castro Aguiar MF, Sallem CC, Lima MPP et al (2023) Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art. Ageing Res Rev 84:101834","journal-title":"Ageing Res Rev"},{"issue":"1","key":"6135_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-023-02933-4","volume":"21","author":"AD Geerlings","year":"2023","unstructured":"Geerlings AD, Kapelle WM, Sederel CJ, Tenison E, Wijngaards-Berenbroek H, Meinders MJ et al (2023) Caregiver burden in Parkinson\u2019s disease: a mixed-methods study. BMC Med 21(1):247","journal-title":"BMC Med"},{"issue":"5 Suppl","key":"6135_CR7","first-page":"S83","volume":"23","author":"D Fredericks","year":"2017","unstructured":"Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW (2017) Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden. Am J Manag Care 23(5 Suppl):S83-s92","journal-title":"Am J Manag Care"},{"issue":"5","key":"6135_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/mds.30162","volume":"40","author":"RMA de Bie","year":"2025","unstructured":"de Bie RMA, Katzenschlager R, Swinnen B, Peball M, Lim SY, Mestre TA et al (2025) Update on treatments for Parkinson\u2019s disease motor fluctuations - an International Parkinson and Movement Disorder Society evidence-based medicine review. Movement disorders\u202f: official journal of the Movement Disorder Society 40(5):776\u2013794","journal-title":"Mov Dis: Off J Mov Dis Soc"},{"issue":"2","key":"6135_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ncl.2024.12.014","volume":"43","author":"S Bellows","year":"2025","unstructured":"Bellows S (2025) Physiotherapy and exercise in Parkinson\u2019s disease. Neurol Clin 43(2):427\u2013443","journal-title":"Neurol Clin"},{"issue":"10291","key":"6135_CR10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet (London, England) 397(10291):2284\u20132303","journal-title":"Lancet (London, England)"},{"key":"6135_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215996","volume":"553","author":"B Liu","year":"2023","unstructured":"Liu B, Cheng L, Gao H, Zhang J, Dong Y, Gao W et al (2023) The biology of VSIG4: implications for the treatment of immune-mediated inflammatory diseases and cancer. Cancer Lett 553:215996","journal-title":"Cancer Lett"},{"issue":"6","key":"6135_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jcyt.2022.12.004","volume":"25","author":"Y Li","year":"2023","unstructured":"Li Y, Wang Q, Li J, Li A, Wang Q, Zhang Q et al (2023) Therapeutic modulation of V set and Ig domain-containing 4 (VSIG4) signaling in immune and inflammatory diseases. Cytotherapy 25(6):561\u2013572","journal-title":"Cytotherapy"},{"issue":"4","key":"6135_CR13","doi-asserted-by":"publisher","first-page":"37810","DOI":"10.31083\/FBL37810","volume":"30","author":"H Lu","year":"2025","unstructured":"Lu H, Li Y, Zhang Y, Qin W, Su Z, Qiu S et al (2025) VSIG4 alleviates intracranial hemorrhage injury by regulating oxidative stress and neuroinflammation in macrophages via the NRF2\/HO-1 signaling pathway. Frontiers in bioscience (Landmark edition) 30(4):37810","journal-title":"Front Biosci (Landmark edition)"},{"issue":"1","key":"6135_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12640-021-00456-5","volume":"40","author":"N Ji","year":"2022","unstructured":"Ji N, Wu L, Shi H, Li Q, Yu A, Yang Z (2022) VSIG4 attenuates NLRP3 and ameliorates neuroinflammation via JAK2-STAT3-A20 pathway after intracerebral hemorrhage in mice. Neurotox Res 40(1):78\u201388","journal-title":"Neurotox Res"},{"key":"6135_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.833402","volume":"14","author":"J Xu","year":"2022","unstructured":"Xu J, Zhou H, Xiang G (2022) Identification of key biomarkers and pathways for maintaining cognitively normal brain aging based on integrated bioinformatics analysis. Front Aging Neurosci 14:833402","journal-title":"Front Aging Neurosci"},{"key":"6135_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578345","volume":"391","author":"P Cai","year":"2024","unstructured":"Cai P, Wang J, Xu J, Zhang M, Yin X, He S et al (2024) V-set and immunoglobulin domain containing 4 inhibits oxidative stress, mitochondrial dysfunction, and inflammation to attenuate Parkinson\u2019s disease progression by activating the JAK2\/STAT3 pathway. J Neuroimmunol 391:578345","journal-title":"J Neuroimmunol"},{"issue":"1","key":"6135_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7426","volume":"5","author":"X Huang","year":"2019","unstructured":"Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S et al (2019) VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1\u03b2 in macrophages. Sci Adv 5(1):eaau7426","journal-title":"Sci Adv"},{"issue":"1","key":"6135_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Diao B, Guo S, Huang X, Yang C, Feng Z et al (2017) VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun 8(1):1322","journal-title":"Nat Commun"},{"issue":"39","key":"6135_CR19","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC et al (2017) Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain. Proc Natl Acad Sci U S A 114(39):E8284-e8293","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"6135_CR20","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013076","volume":"13","author":"OC Kwon","year":"2021","unstructured":"Kwon OC, Song JJ, Yang Y, Kim SH, Kim JY, Seok MJ et al (2021) SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models. EMBO Mol Med 13(4):e13076","journal-title":"EMBO Mol Med"},{"issue":"5","key":"6135_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.15252\/emmm.201404610","volume":"7","author":"SM Oh","year":"2015","unstructured":"Oh SM, Chang MY, Song JJ, Rhee YH, Joe EH, Lee HS et al (2015) Combined Nurr1 and Foxa2 roles in the therapy of Parkinson\u2019s disease. EMBO Mol Med 7(5):510\u2013525","journal-title":"EMBO Mol Med"},{"issue":"5","key":"6135_CR22","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q et al (2020) Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain\u202f: a journal of neurology 143(5):1476\u20131497","journal-title":"Brain : J Neurol"},{"issue":"10","key":"6135_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL (2018) Microglial signatures and their role in health and disease. Nat Rev Neurosci 19(10):622\u2013635","journal-title":"Nat Rev Neurosci"},{"issue":"18","key":"6135_CR24","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP et al (2016) Inhibition of the JAK\/STAT pathway protects against \u03b1-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36(18):5144\u20135159","journal-title":"J Neurosci"},{"issue":"1","key":"6135_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"YF Hou","year":"2021","unstructured":"Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A, Zhu KC et al (2021) Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 9(1):34","journal-title":"Microbiome"},{"issue":"15","key":"6135_CR26","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M et al (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110(15):2422-2437.e2429","journal-title":"Neuron"},{"key":"6135_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128077","volume":"293","author":"W Zhu","year":"2025","unstructured":"Zhu W, Hu Y, Shi Y, Bao H, Cheng X, Jiang M et al (2025) Sleep deprivation accelerates Parkinson\u2019s disease via modulating gut microbiota associated microglial activation and oxidative stress. Microbiol Res 293:128077","journal-title":"Microbiol Res"},{"issue":"5","key":"6135_CR28","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","volume":"61","author":"P Huang","year":"2024","unstructured":"Huang P, Zhang Z, Zhang P, Feng J, Xie J, Zheng Y et al (2024) TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 cells. Mol Neurobiol 61(5):2590\u20132605","journal-title":"Mol Neurobiol"},{"key":"6135_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105940","volume":"176","author":"A Gopinath","year":"2023","unstructured":"Gopinath A, Mackie PM, Phan LT, Tansey MG, Khoshbouei H (2023) The complex role of inflammation and gliotransmitters in Parkinson\u2019s disease. Neurobiol Dis 176:105940","journal-title":"Neurobiol Dis"},{"issue":"1","key":"6135_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359","journal-title":"Signal Transduct Target Ther"},{"key":"6135_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"issue":"s1","key":"6135_CR32","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.3233\/JPD-223237","volume":"12","author":"N Stefanova","year":"2022","unstructured":"Stefanova N (2022) Microglia in Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S105-s112","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"6135_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbrc.2019.11.077","volume":"522","author":"Q Lyu","year":"2020","unstructured":"Lyu Q, Pang X, Zhang Z, Wei Y, Hong J, Chen H (2020) Microglial V-set and immunoglobulin domain-containing 4 protects against ischemic stroke in mice by suppressing TLR4-regulated inflammatory response. Biochem Biophys Res Commun 522(3):560\u2013567","journal-title":"Biochem Biophys Res Commun"},{"issue":"7116","key":"6135_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature05263","volume":"444","author":"C Wiesmann","year":"2006","unstructured":"Wiesmann C, Katschke KJ, Yin J, Helmy KY, Steffek M, Fairbrother WJ et al (2006) Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444(7116):217\u2013220","journal-title":"Nature"},{"issue":"10","key":"6135_CR35","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/eji.201040323","volume":"40","author":"M Chen","year":"2010","unstructured":"Chen M, Muckersie E, Luo C, Forrester JV, Xu H (2010) Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis. Eur J Immunol 40(10):2870\u20132881","journal-title":"Eur J Immunol"},{"key":"6135_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065914","author":"G Forloni","year":"2023","unstructured":"Forloni G (2023) Alpha synuclein: neurodegeneration and inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065914","journal-title":"Int J Mol Sci"},{"key":"6135_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","volume":"99","author":"M Zubelzu","year":"2022","unstructured":"Zubelzu M, Morera-Herreras T, Irastorza G, G\u00f3mez-Esteban JC, Murueta-Goyena A (2022) Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord 99:107\u2013115","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"6135_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gendis.2018.06.001","volume":"5","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang K, Wan W, Cheng Y, Pu X, Ye X (2018) Resveratrol provides neuroprotection by regulating the JAK2\/STAT3\/PI3K\/AKT\/mTOR pathway after stroke in rats. Genes & diseases 5(3):245\u2013255","journal-title":"Genes Dis"},{"issue":"2","key":"6135_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/cbin.11088","volume":"43","author":"L Chang","year":"2019","unstructured":"Chang L, Liang J, Xia X, Chen X (2019) miRNA-126 enhances viability, colony formation, and migration of keratinocytes HaCaT cells by regulating PI3 K\/AKT signaling pathway. Cell Biol Int 43(2):182\u2013191","journal-title":"Cell Biol Int"},{"issue":"5","key":"6135_CR40","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1074\/jbc.C800206200","volume":"284","author":"KJ Inglis","year":"2009","unstructured":"Inglis KJ, Chereau D, Brigham EF, Chiou SS, Sch\u00f6bel S, Frigon NL et al (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284(5):2598\u20132602","journal-title":"J Biol Chem"},{"key":"6135_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2017.06.014","volume":"106","author":"RH Kofoed","year":"2017","unstructured":"Kofoed RH, Zheng J, Ferreira N, Lykke-Andersen S, Salvi M, Betzer C et al (2017) Polo-like kinase 2 modulates \u03b1-synuclein protein levels by regulating its mRNA production. Neurobiol Dis 106:49\u201362","journal-title":"Neurobiol Dis"},{"key":"6135_CR42","doi-asserted-by":"publisher","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","volume":"11","author":"Q Hu","year":"2023","unstructured":"Hu Q, Bian Q, Rong D, Wang L, Song J, Huang HS et al (2023) JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens. Frontiers in bioengineering and biotechnology 11:1110765","journal-title":"Front Bioeng Biotech"},{"issue":"1","key":"6135_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.14336\/AD.2023.0515","volume":"15","author":"XY Dai","year":"2024","unstructured":"Dai XY, Liu L, Song FH, Gao SJ, Wu JY, Li DY et al (2024) Targeting the JAK2\/STAT3 signaling pathway for chronic pain. Aging Dis 15(1):186\u2013200","journal-title":"Aging Dis"},{"issue":"2","key":"6135_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jaci.2024.09.020","volume":"155","author":"S Samra","year":"2025","unstructured":"Samra S, Bergerson JRE, Freeman AF, Turvey SE (2025) JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. J Allergy Clin Immunol 155(2):357\u2013367","journal-title":"J Allergy Clin Immunol"},{"key":"6135_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.848813","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Yv Q, Ye F, Chen S, He Z, Li W et al (2022) Echinacoside protects dopaminergic neurons through regulating IL-6\/JAK2\/STAT3 pathway in Parkinson\u2019s disease model. Front Pharmacol 13:848813","journal-title":"Front Pharmacol"},{"key":"6135_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuro.2017.04.001","volume":"64","author":"L Yin","year":"2018","unstructured":"Yin L, Dai Q, Jiang P, Zhu L, Dai H, Yao Z et al (2018) Manganese exposure facilitates microglial JAK2-STAT3 signaling and consequent secretion of TNF-a and IL-1\u03b2 to promote neuronal death. Neurotoxicology 64:195\u2013203","journal-title":"Neurotoxicology"},{"issue":"2","key":"6135_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5603\/FHC.a2020.0011","volume":"58","author":"D He","year":"2020","unstructured":"He D, Chen S, Xiao Z, Wu H, Zhou G, Xu C et al (2020) Bisdemethoxycurcumin exerts a cell-protective effect via JAK2\/STAT3 signaling in a rotenone-induced Parkinson\u2019s disease model in vitro. Folia Histochem Cytobiol 58(2):127\u2013134","journal-title":"Folia Histochem Cytobiol"},{"key":"6135_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.631501","volume":"15","author":"Z Xu","year":"2021","unstructured":"Xu Z, Yang D, Huang X, Huang H (2021) Astragaloside IV protects 6-hydroxydopamine-induced SH-SY5Y cell model of Parkinson\u2019s disease via activating the JAK2\/STAT3 pathway. Front Neurosci 15:631501","journal-title":"Front Neurosci"},{"issue":"1","key":"6135_CR49","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","volume":"12","author":"D Dutta","year":"2021","unstructured":"Dutta D, Jana M, Majumder M, Mondal S, Roy A, Pahan K (2021) Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo. Nat Commun 12(1):5382","journal-title":"Nat Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06135-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06135-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06135-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:15:32Z","timestamp":1787843732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06135-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6135"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06135-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All housing and procedures followed the National Institutes of Health Guidelines and were approved by the Animal Care and Use Committee.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical Trial Registration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"860"}}